๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow : A report of the Children's Cancer Group

โœ Scribed by Lawrence J. Ettinger; Percy Ivy; Paul S. Gaynon; Alice G. Ettinger; Wen Liu-Mares; Mark D. Krailo


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
79 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

Carboplatin is an analogue of cisplatin with less nonhematologic toxicity


๐Ÿ“œ SIMILAR VOLUMES


Bone marrow transplantation versus chemo
โœ Feig, Stephen A.; Harris, Richard E.; Sather, Harland N. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB ๐Ÿ‘ 1 views

Background. Maintenance of second remission of childhood acute lymphoblastic leukemia (ALL) with intensive chemotherapy is often unsuccessful. The major cause of treatment failure is relapse. Materials and Methods. Of 96 children with ALL who relapsed in the marrow while on or within 1 year of comp

Prognostic significance of cytogenetic a
โœ Nyla A. Heerema; Harland N. Sather; Martha G. Sensel; Mei K. Lee; Raymond Hutchi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 1 views

## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##

A Phase I study of granulocyte-macrophag
โœ Mitchell S. Cairo; Mark D. Krailo; Joel A. Weinthal; Rita Secola; Sharon Bergero ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 1 views

## Background: This phase i trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of pixy321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tumors. ## Methods: Children (age < 22 years a

Clinical significance of Philadelphia ch
โœ Fatih M. Uckun; James B. Nachman; Harland N. Sather; Martha G. Sensel; Peter Kra ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 1 views

## BACKGROUND. Children with Philadelphia (Ph) chromosome positive ( ฯฉ ) acute lymphoblastic leukemia (ALL) represent a subgroup at very high risk for treatment failure. In this report, the authors assessed the outcome of Ph ฯฉ ALL in a large cohort of children treated on contemporary intensive che